Partnership · Healthcare & Life Sciences

Redcliffe Labs partners with Skyroot Aerospace for space diagnostics

By Startup Enthusiast · 14 August 2026

What they do

Redcliffe Labs is an omnichannel diagnostic service provider with labs across 220+ cities

It has partnered with Skyroot Aerospace to test dry diagnostic reagents in Low Earth Orbit for 90 days

The experiment could help develop diagnostic products for space missions and remote areas with limited lab infrastructure

Redcliffe Labs and Skyroot Aerospace have partnered to test diagnostic reagents in space.
The first experiment, named DRIFT-1, will place Redcliffe's dry diagnostic reagents in Low Earth Orbit for 90 days.
The performance of the space-exposed reagents will be compared with an identical control sample maintained on Earth.
The experiment aims to examine how the space environment affects reagent stability and performance.
The initiative is expected to generate flight data for diagnostic technologies for space missions and challenging Earth environments.
Findings could help develop diagnostic products for locations with limited lab infrastructure or cold-chain facilities.
Potential applications include astronaut healthcare, life sciences, microgravity research, and point-of-care diagnostics for human spaceflight programmes such as Gaganyaan and Bharatiya Antariksh Station.
The statement did not disclose the launch timeline, rocket or spacecraft, number or types of reagents, or financial terms of the partnership.

Redcliffe Labs recently divested its fertility services business Crysta IVF to focus on diagnostics.
Skyroot Aerospace conducted the first orbital rocket launch by an Indian private company in July 2026.
The partnership could open new applications for diagnostics in space and remote areas.

Redcliffe Labs is an omnichannel diagnostic service provider offering pathology and diagnostic services through labs, collection centres, and home sample collection.
It operates across more than 220 cities and offers over 3,600 diagnostic tests.
The company has 80+ self-owned certified labs, 2,000+ collection centres, and 1,500+ trained phlebotomists.
It has touched over 1 crore lives.

The partnership aims to generate flight data for diagnostic technologies for space missions and challenging Earth environments.
Findings could lead to diagnostic products for locations with limited lab infrastructure or cold-chain facilities.
Potential applications include astronaut healthcare, life sciences, microgravity research, and point-of-care diagnostics for human spaceflight programmes including Gaganyaan and Bharatiya Antariksh Station.